Banque Cantonale Vaudoise Edwards Lifesciences Corp Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 81,111 shares of EW stock, worth $5.5 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

81,111

Previous 55,225 46.87%

Holding current value

$5.5 Million

Previous $5.1 Million 4.94%

% of portfolio

0.22%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$59.7 - $93.78 $1.55 Million - $2.43 Million	25,886 Added 46.87%	81,111 $5.35 Million
Q2 2024 Jul 31, 2024	SELL	$84.3 - $94.31 $251,719 - $281,609	-2,986 Reduced 5.13%	55,225 $5.1 Million
Q1 2024 Apr 10, 2024	SELL	$72.54 - $95.56 $125,058 - $164,745	-1,724 Reduced 2.88%	58,211 $5.56 Million
Q4 2023 Feb 07, 2024	BUY	$61.71 - $77.76 $1.58 Million - $2 Million	25,671 Added 74.92%	59,935 $4.57 Million
Q3 2023 Nov 08, 2023	BUY	$69.28 - $93.38 $272,893 - $367,823	3,939 Added 12.99%	34,264 $2.38 Million
Q2 2023 Aug 09, 2023	BUY	$81.41 - $94.33 $422,762 - $489,855	5,193 Added 20.66%	30,325 $2.86 Million
Q1 2023 Apr 20, 2023	SELL	$74.26 - $84.51 $290,282 - $330,349	-3,909 Reduced 13.46%	25,132 $2.08 Million
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $150,123 - $192,193	-2,198 Reduced 7.04%	29,041 $2.17 Million
Q3 2022 Oct 17, 2022	SELL	$82.37 - $107.29 $1,070 - $1,394	-13 Reduced 0.04%	31,239 $2.58 Million
Q2 2022 Aug 02, 2022	SELL	$86.5 - $128.27 $98,264 - $145,714	-1,136 Reduced 3.51%	31,252 $2.97 Million
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $97,371 - $122,564	-955 Reduced 2.86%	32,388 $3.81 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $615,563 - $756,245	-5,787 Reduced 14.79%	33,343 $4.32 Million
Q3 2021 Oct 29, 2021	BUY	$102.91 - $122.75 $269,727 - $321,727	2,621 Added 7.18%	39,130 $4.43 Million
Q2 2021 Aug 11, 2021	SELL	$83.84 - $104.76 $136,407 - $170,444	-1,627 Reduced 4.27%	36,509 $3.78 Million
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $245,245 - $282,618	-3,117 Reduced 7.56%	38,136 $3.19 Million
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $61,868 - $78,731	863 Added 2.14%	41,253 $3.76 Million
Q3 2020 Oct 30, 2020	SELL	$67.19 - $87.44 $7,458 - $9,705	-111 Reduced 0.27%	40,390 $3.22 Million
Q2 2020 Jul 22, 2020	BUY	$57.54 - $76.95 $1.71 Million - $2.29 Million	29,736 Added 276.23%	40,501 $2.8 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $191,139 - $295,407	-3,647 Reduced 25.31%	10,765 $2.03 Million
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $1.03 Million - $1.18 Million	14,412 New	14,412 $3.36 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Edwards Lifesciences Corp Transaction History